IART Stock Analysis: Buy, Sell, or Hold?
IART - Integra LifeSciences Holdings
$17.60
0.02 (0.11%)
▲
5d:
-0.96%
30d:
+14.36%
90d:
+96.87%
WAIT
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Get Alerted When IART Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: IART shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: IART shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.73
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$10.39
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IART is currently trading at $17.60, which is considered extended relative to its 30-day fair value range of $14.65 to $17.31. From a valuation perspective, the stock is trading at a premium (Forward PE: 6.7) compared to its historical average (4.9). At these levels, the market is pricing in 10.8% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, IART is in a strong uptrend. Immediate support is located at $16.75, while resistance sits at $18.30.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IART is in a strong uptrend. Immediate support is located at $16.75, while resistance sits at $18.30.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$14.65 -
$17.31
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
41.4%
Protect Your Profits
Holding IART? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($17.43)
- BEARISH: Market expects 10.8% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$14.65 -
$17.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$16.75
Resistance Level
$18.30
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.72
Wall Street Target
$17.43
(-1.0%)
Revenue Growth (YoY)
2.4%
Earnings Growth (YoY)
0.4%
Profit Margin
-30.1%
Valuation Premium vs History
+10.8% premium
PE vs Historical
6.7 vs 4.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.8%
(market-implied from PE analysis)
1-Year Target
$19.50
(+11%)
2-Year Target
$21.61
(+23%)
3-Year Target
$23.94
(+36%)
3-Yr Target (if PE normalizes)
(PE: 7→5)
PE COMPRESSION
$17.45
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 6.9%)
$69.65
(+296%)
Base:
(SPY PE: 6.7, Growth: 6.9%)
$21.49
(+22%)
Bear:
(PE: 4.9, Growth: 6.9%)
$15.67
(-11%)
Share & Embed Analysis
Last updated: June 23, 2026 7:48 AM ET
Data refreshes hourly during market hours. Next update: 8:48 AM
Data refreshes hourly during market hours. Next update: 8:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IART showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
Advanced IART Option Strategies
Professional options setups generated by AI based on today's IART price and gamma walls.
